Speaker Profile
Ph.D., CSO, Cellanome
Biography
Dr. Gary Schroth is a globally recognized genomics leader and scientific innovator with over 30 years of experience advancing next-generation sequencing (NGS) technologies and their applications across biology and medicine. As Chief Scientific Officer at Cellanome, Dr. Schroth leads the companys RD, scientific collaborations, and innovation strategy, guiding the development of cutting-edge tools that power Cellanomes next-generation cell biology platform. Dr. Schroths vision at Cellanome is to integrate the companys proprietary technologies with state-of-the-art AI, and bioinformatics to achieve a new level of resolution and accuracy in cellular measurement. He oversees multidisciplinary teams advancing Cellanomes product portfolio, research partnerships, and scientific communications, ensuring Cellanomes innovations have broad impact across oncology, immunology, and developmental biology. Before joining Cellanome, Dr. Schroth was Vice President and Distinguished Scientist at Illumina, where he led the Core Applications Group in Product Development and helped expand the frontiers of sequencing applications in cancer, immunology, and infectious disease. His earlier career includes senior RD roles at Solexa, Applied Biosystems, Genelabs Technologies, and Gen-Probe. Dr. Schroth holds a PhD and Bachelor of Science in Biochemistry from the University of California, Davis, has authored over 125 peer-reviewed papers, and is the inventor on 19 U. S. patents.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• W.E. Moerner, Stanford
• Serge Saxonov, 10x Genomics
• Priscilla Chan, Biohub
Honoree Fireside
• Christina Curtis, Stanford
• Priscilla Chan, Biohub
Honoree Fireside: From Measurement to Meaning: What Data AI Still Needs in Biology
• Christina Curtis, Stanford
• W.E. Moerner, Stanford
• Serge Saxonov, 10x Genomics
Unraveling Tissue Architecture with Single-Cell & Spatial Multi-Omics
• Chair: Garry P. Nolan, Stanford
• Joakim Lundeberg, SciLifeLab
• Tae Hyun Hwang, Vanderbilt University Medical Center
• Michael Angelo, Stanford
Spatial Sequencing for Next Generation Pathology
• Eli Glezer, Singular Genomics
Precision Profiling of Cells: Insights from Imaging-Spectral Flow Cytometry and Single-Cell Multiomics
• Aruna Ayer, BD
Single-Cell Genotype and Targeted Gene Expression Assay
• Zivjena Vucetic, Mission Bio
Resolving Cellular Lineage and State in Tumors with High-Resolution Single-Cell Genomics
• Gary Schroth, Cellanome
From Cellular State to Disease Gene Prediction at Population Scale
• Kyle Farh, Illumina
Tumor Evolution & Clonal Dynamics: From Models to Monitoring
• Christina Curtis, Stanford
Personal Omics at Scale: What Longitudinal Profiles Add to Early Detection
• Michael Snyder, Stanford
Multi-Omics-Driven Early Detection: Beyond Liquid Biopsy
• Chair: Alex Aravanis, Moonwalk Biosciences
• Ash Alizadeh, Stanford
• Sara Ahadi, OmicsEra
AI in Molecular Diagnostics: Integrating Multi-Omics & Clinical Data
• Chair: Marina Sirota, UCSF
• Olivier Gevaert, Stanford
• Rebecca Critchley-Thorne, Castle Biosciences
• Lihua Jiang, Stanford
• Yunguan Wang, Cincinnati Children's
